risks of taking tirzepatide Injections for Medical Weight Loss in Fayetteville NC Tirzepatide Dosing - A Patient

Dancy BM et al

The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major adverse cardiovascular events (MACE) in patients with obesity and established cardiovascular disease

Any suspected side effects should be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app

Safer alternatives include NHS weight management services, licensed monotherapy options such as orlistat, liraglutide, semaglutide, or naltrexone-bupropion, and bariatric surgery for eligible patients

If you experience these symptoms, check your blood glucose if possible and treat with fast-acting carbohydrate (e.g., glucose tablets, sugary drink)